Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-21

FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Fluoxetine Hydrochloride from Lannett Company, Inc., a generic fluoxetine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluoxetine (Fluoxetine)

Snippet

SUPPL AP for FLUOXETINE (FLUOXETINE HYDROCHLORIDE)